(ARM) Arm Holdings American - Overview
Exchange: NASDAQ •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US0420682058
Stock: Processors, Graphics, Software, Tools, Licensing
Total Rating 43
Risk 87
Buy Signal -1.01
| Risk 5d forecast | |
|---|---|
| Volatility | 63.6% |
| Relative Tail Risk | -8.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.15 |
| Alpha | -46.19 |
| Character TTM | |
|---|---|
| Beta | 2.684 |
| Beta Downside | 2.149 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.97% |
| CAGR/Max DD | 0.50 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 162.2933
Description: ARM Arm Holdings American March 04, 2026
Arm Holdings plc designs and licenses CPU products and related technologies to semiconductor companies and original equipment manufacturers. This intellectual property (IP) licensing model is common in the semiconductor industry, allowing specialized design firms to focus on innovation without manufacturing overhead.
The companys offerings include microprocessors, graphics processing units, and system IP. These products are utilized across diverse sectors, including automotive, computing infrastructure, and IoT. A key aspect of Arms business model is its extensive ecosystem of partners who integrate Arms architecture into their own products.
Arm Holdings operates globally, with significant presence in the US, China, and Taiwan, reflecting the global nature of semiconductor supply chains. The company, founded in 1990, is a subsidiary of SoftBank Group Corp.
To gain further insights into Arms market position and financial health, consider exploring its detailed analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 801.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.16 > 1.0 |
| NWC/Revenue: 100.2% < 20% (prev 93.67%; Δ 6.51% < -1%) |
| CFO/TA 0.15 > 3% & CFO 1.52b > Net Income 801.0m |
| Net Debt (-1.95b) to EBITDA (1.05b): -1.86 < 3 |
| Current Ratio: 5.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.07b) vs 12m ago 0.47% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 50.03% > 50% (prev 43.48%; Δ 6.55% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z'' 6.93
| A: 0.46 (Total Current Assets 5.74b - Total Current Liabilities 1.06b) / Total Assets 10.18b |
| B: 0.41 (Retained Earnings 4.13b / Total Assets 10.18b) |
| C: 0.09 (EBIT TTM 820.0m / Avg Total Assets 9.34b) |
| D: 1.90 (Book Value of Equity 4.53b / Total Liabilities 2.38b) |
| Altman-Z'' Score: 6.93 = AAA |
Beneish M -3.06
| DSRI: 1.00 (Receivables 2.01b/1.59b, Revenue 4.67b/3.69b) |
| GMI: 0.99 (GM 95.43% / 94.04%) |
| AQI: 0.76 (AQ_t 0.32 / AQ_t-1 0.42) |
| SGI: 1.26 (Revenue 4.67b / 3.69b) |
| TATA: -0.07 (NI 801.0m - CFO 1.52b) / TA 10.18b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of ARM shares?
As of March 07, 2026, the stock is trading at USD 114.38 with a total of 4,180,145 shares traded.
Over the past week, the price has changed by -10.26%, over one month by -7.53%, over three months by -18.17% and over the past year by -3.00%.
Over the past week, the price has changed by -10.26%, over one month by -7.53%, over three months by -18.17% and over the past year by -3.00%.
Is ARM a buy, sell or hold?
Arm Holdings American has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold ARM.
- StrongBuy: 17
- Buy: 5
- Hold: 14
- Sell: 1
- StrongSell: 3
What are the forecasts/targets for the ARM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 147.7 | 29.1% |
| Analysts Target Price | 147.7 | 29.1% |
ARM Fundamental Data Overview March 05, 2026
P/E Trailing = 162.2933
P/E Forward = 54.9451
P/S = 27.6743
P/B = 16.9378
P/EG = 1.709
Revenue TTM = 4.67b USD
EBIT TTM = 820.0m USD
EBITDA TTM = 1.05b USD
Long Term Debt = 461.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 64.0m USD (from shortTermDebt, last quarter)
Debt = 858.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.95b USD (from netDebt column, last quarter)
Enterprise Value = 126.58b USD (129.27b + Debt 858.0m - CCE 3.54b)
Interest Coverage Ratio = unknown (Ebit TTM 820.0m / Interest Expense TTM 0.0)
EV/FCF = 130.5x (Enterprise Value 126.58b / FCF TTM 970.0m)
FCF Yield = 0.77% (FCF TTM 970.0m / Enterprise Value 126.58b)
FCF Margin = 20.77% (FCF TTM 970.0m / Revenue TTM 4.67b)
Net Margin = 17.15% (Net Income TTM 801.0m / Revenue TTM 4.67b)
Gross Margin = unknown ((Revenue TTM 4.67b - Cost of Revenue TTM 213.5m) / Revenue TTM)
Tobins Q-Ratio = 12.44 (Enterprise Value 126.58b / Total Assets 10.18b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 858.0m)
Taxrate = 2.19% (5.00m / 228.0m)
NOPAT = 802.0m (EBIT 820.0m * (1 - 2.19%))
Current Ratio = 5.43 (Total Current Assets 5.74b / Total Current Liabilities 1.06b)
Debt / Equity = 0.11 (Debt 858.0m / totalStockholderEquity, last quarter 7.80b)
Debt / EBITDA = -1.86 (Net Debt -1.95b / EBITDA 1.05b)
Debt / FCF = -2.01 (Net Debt -1.95b / FCF TTM 970.0m)
Total Stockholder Equity = 7.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.58% (Net Income 801.0m / Total Assets 10.18b)
RoE = 11.03% (Net Income TTM 801.0m / Total Stockholder Equity 7.26b)
RoCE = 10.62% (EBIT 820.0m / Capital Employed (Equity 7.26b + L.T.Debt 461.0m))
RoIC = 11.04% (NOPAT 802.0m / Invested Capital 7.26b)
WACC = 15.71% (E(129.27b)/V(130.12b) * Re(15.81%) + D(858.0m)/V(130.12b) * Rd(0.0%) * (1-Tc(0.02)))
Discount Rate = 15.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.95%
[DCF] Terminal Value 53.72% ; FCFF base≈832.4m ; Y1≈789.3m ; Y5≈751.4m
[DCF] Fair Price = 6.94 (EV 5.42b - Net Debt -1.95b = Equity 7.37b / Shares 1.06b; r=15.71% [WACC]; 5y FCF grow -6.72% → 2.90% )
EPS Correlation: 63.63 | EPS CAGR: 26.36% | SUE: 1.08 | # QB: 2
Revenue Correlation: 93.45 | Revenue CAGR: 18.19% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.38 | Chg7d=+0.002 | Chg30d=-0.076 | Revisions Net=-17 | Analysts=25
EPS next Year (2027-03-31): EPS=2.16 | Chg7d=-0.000 | Chg30d=-0.123 | Revisions Net=-20 | Growth EPS=+22.8% | Growth Revenue=+20.3%
[Analyst] Revisions Ratio: -0.81 (2 Up / 19 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 15.2% (Discount Rate 15.8% - Earnings Yield 0.6%)
[Growth] Growth Spread = +5.5% (Analyst 20.7% - Implied 15.2%)
P/E Forward = 54.9451
P/S = 27.6743
P/B = 16.9378
P/EG = 1.709
Revenue TTM = 4.67b USD
EBIT TTM = 820.0m USD
EBITDA TTM = 1.05b USD
Long Term Debt = 461.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 64.0m USD (from shortTermDebt, last quarter)
Debt = 858.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.95b USD (from netDebt column, last quarter)
Enterprise Value = 126.58b USD (129.27b + Debt 858.0m - CCE 3.54b)
Interest Coverage Ratio = unknown (Ebit TTM 820.0m / Interest Expense TTM 0.0)
EV/FCF = 130.5x (Enterprise Value 126.58b / FCF TTM 970.0m)
FCF Yield = 0.77% (FCF TTM 970.0m / Enterprise Value 126.58b)
FCF Margin = 20.77% (FCF TTM 970.0m / Revenue TTM 4.67b)
Net Margin = 17.15% (Net Income TTM 801.0m / Revenue TTM 4.67b)
Gross Margin = unknown ((Revenue TTM 4.67b - Cost of Revenue TTM 213.5m) / Revenue TTM)
Tobins Q-Ratio = 12.44 (Enterprise Value 126.58b / Total Assets 10.18b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 858.0m)
Taxrate = 2.19% (5.00m / 228.0m)
NOPAT = 802.0m (EBIT 820.0m * (1 - 2.19%))
Current Ratio = 5.43 (Total Current Assets 5.74b / Total Current Liabilities 1.06b)
Debt / Equity = 0.11 (Debt 858.0m / totalStockholderEquity, last quarter 7.80b)
Debt / EBITDA = -1.86 (Net Debt -1.95b / EBITDA 1.05b)
Debt / FCF = -2.01 (Net Debt -1.95b / FCF TTM 970.0m)
Total Stockholder Equity = 7.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.58% (Net Income 801.0m / Total Assets 10.18b)
RoE = 11.03% (Net Income TTM 801.0m / Total Stockholder Equity 7.26b)
RoCE = 10.62% (EBIT 820.0m / Capital Employed (Equity 7.26b + L.T.Debt 461.0m))
RoIC = 11.04% (NOPAT 802.0m / Invested Capital 7.26b)
WACC = 15.71% (E(129.27b)/V(130.12b) * Re(15.81%) + D(858.0m)/V(130.12b) * Rd(0.0%) * (1-Tc(0.02)))
Discount Rate = 15.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.95%
[DCF] Terminal Value 53.72% ; FCFF base≈832.4m ; Y1≈789.3m ; Y5≈751.4m
[DCF] Fair Price = 6.94 (EV 5.42b - Net Debt -1.95b = Equity 7.37b / Shares 1.06b; r=15.71% [WACC]; 5y FCF grow -6.72% → 2.90% )
EPS Correlation: 63.63 | EPS CAGR: 26.36% | SUE: 1.08 | # QB: 2
Revenue Correlation: 93.45 | Revenue CAGR: 18.19% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.38 | Chg7d=+0.002 | Chg30d=-0.076 | Revisions Net=-17 | Analysts=25
EPS next Year (2027-03-31): EPS=2.16 | Chg7d=-0.000 | Chg30d=-0.123 | Revisions Net=-20 | Growth EPS=+22.8% | Growth Revenue=+20.3%
[Analyst] Revisions Ratio: -0.81 (2 Up / 19 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 15.2% (Discount Rate 15.8% - Earnings Yield 0.6%)
[Growth] Growth Spread = +5.5% (Analyst 20.7% - Implied 15.2%)